A-Kinase Anchor Protein 7 Isoform Gamma (AKAP7) Antibody (FITC)

Este producto es parte de AKAP - A kinase anchor protein
Product Graph
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
A-Kinase Anchor Protein 7 Isoform Gamma (AKAP7) Antibody (FITC)
category
Primary Antibodies
provider
Abbexa
reference
abx303026

Description

AKAP7 Antibody (FITC) is a Rabbit Polyclonal against AKAP7 conjugated to FITC.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
A-Kinase Anchor Protein 7 Isoform Gamma (AKAP7)
Host
Rabbit
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
FITC
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid exposure to light. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
O43687
Gene ID
9465
NCBI Accession
NP_004833.1, NM_004842.3, NP_619539.1, NM_138633.2
OMIM
604693
Alias
AKAP7, AKAP18
Background
Antibody anti-AKAP7
Status
RUO

Descripción

AKAP7, also referred to as AKAP15/18, is a small, membrane-associated scaffold protein that localizes PKA and other signaling molecules to the plasma membrane and sarcoplasmic reticulum (SR) in excitable cells, such as neurons and cardiac myocytes. AKAP7 regulates PKA-dependent phosphorylation of L-type calcium channels, ensuring proper calcium influx during action potentials, which is critical for cardiac and neuronal excitability. It also interacts with phospholamban to modulate SR calcium uptake through SERCA2 pumps, impacting cardiac muscle relaxation. AKAP7 isoforms have diverse roles, with AKAP18γ and AKAP18δ being involved in anchoring signaling components to SR and plasma membranes. Dysregulation of AKAP7 impairs calcium handling, leading to arrhythmias, cardiac dysfunction, and impaired synaptic plasticity. AKAP7 has also been implicated in insulin secretion in pancreatic beta cells, where it organizes signaling components involved in glucose-stimulated calcium responses.

Related Products

FNab00257

anti- AKAP7 antibody

Probably targets cAMP-dependent protein kinase(PKA) to the cellular membrane or cytoskeletal structures. The membrane-associated form reduces epithelial sodium channel(ENaC) activity, whereas the free cytoplasmic form may negatively regulate ENaC channel feedback inhibition by intracellular sodium.

Ver Producto
P4173

Recombinant Human AKAP7

Ver Producto
P8046

Recombinant Human AKAP7

Ver Producto